These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4141901)

  • 1. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS; Meyer D; Dreyfus MD; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
    Barbui T; Battista R; Dini E
    Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
    [No Abstract]   [Full Text] [Related]  

  • 4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet responses to ristocetin in von Willebrand's disease.
    Sanderson JH; Burn AM; Cooke S
    Scand J Haematol; 1974; 12(4):249-55. PubMed ID: 4545782
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
    Hougie C; Sargeant RB; Brown JE; Baugh RF
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
    Coller BS; Hirschman RJ; Gralnick HR
    Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
    [No Abstract]   [Full Text] [Related]  

  • 9. Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.
    Meyer D; Jenkins CS; Dreyfus MD; Fressinaud E; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):579-99. PubMed ID: 4549013
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation of human factor VIII activity from the von Willebrand's antigen and ristocetin platelet aggregating activity.
    Baugh R; Brown J; Sargeant R; Hougie C
    Biochim Biophys Acta; 1974 Dec; 371(2):360-7. PubMed ID: 4433572
    [No Abstract]   [Full Text] [Related]  

  • 11. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
    Niessner H
    Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human platelet aggregation by the proteolytic effect of streptokinase. Role of the human factor-VIII-related protein.
    Castillo R; Maragall S; Guisasola JA; Casals F; Profitós J; Ordinas A
    Haemostasis; 1976; 5(5):306-17. PubMed ID: 1087912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand's disease type B: a newly defined bleeding diathesis.
    Firkin B; Firkin F; Stott L
    Aust N Z J Med; 1973 Jun; 3(3):225-9. PubMed ID: 4125893
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].
    Ogata K; Minami S; Kamiya T
    Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet retention in glass bead columns: further evidence for the importance of ADP.
    McPherson VJ; Zucker MB; Friedberg NM; Rifkin PL
    Blood; 1974 Sep; 44(3):411-25. PubMed ID: 4369023
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects.
    Girolami A; De Marco L; Virgolini L; Peruffo R; Fabris F
    Blut; 1975 Oct; 31(4):219-26. PubMed ID: 1080679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.